A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Launched by UCB BIOPHARMA SRL · Jul 14, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The participant could, in the opinion of the Investigator, benefit from long-term dapirolizumab pegol (DZP) treatment
- • The participant completed one of the parent studies within 4 weeks prior to entry to this study
- Exclusion Criteria:
- • - Study participant has any medical or psychiatric condition (including conditions due to neuropsychiatric systemic lupus erythematosus (SLE)) that, in the opinion of the Investigator, could jeopardize or would compromise the study participant's ability to participate in this study. This includes study participants with a life-threatening condition or ongoing malignancies at the start of the study
About Ucb Biopharma Srl
UCB Biopharma Srl is a global biopharmaceutical company dedicated to the discovery and development of innovative therapies for patients with severe diseases, particularly in the fields of neurology and immunology. With a strong commitment to research and development, UCB leverages cutting-edge science and patient insights to create effective treatment solutions that improve the quality of life for individuals affected by complex conditions. The company fosters collaboration with healthcare professionals and stakeholders to advance its clinical programs and bring new therapies to market, underscoring its mission to transform patient care through science-driven approaches.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tucson, Arizona, United States
Beverly Hills, California, United States
La Palma, California, United States
San Leandro, California, United States
Denver, Colorado, United States
Ormond Beach, Florida, United States
Tampa, Florida, United States
Idaho Falls, Idaho, United States
Hagerstown, Maryland, United States
Charlotte, North Carolina, United States
Jackson, Tennessee, United States
Beckley, West Virginia, United States
Tucuman, , Argentina
Bruxelles, , Belgium
Plovdiv, , Bulgaria
Plovdiv, , Bulgaria
Sofia, , Bulgaria
Rimouski, , Canada
Trois Rivieres, , Canada
Santiago De Chile, , Chile
Leipzig, , Germany
Budapest, , Hungary
Szekesfehervar, , Hungary
Bydgoszcz, , Poland
Katowice, , Poland
Krakow, , Poland
Lublin, , Poland
Poznan, , Poland
Poznan, , Poland
Warszawa, , Poland
Warszawa, , Poland
Wroclaw, , Poland
Belgrade, , Serbia
Sabadell, , Spain
Vigo, , Spain
Taichung, , Taiwan
Taipei, , Taiwan
Las Vegas, Nevada, United States
Bialystok, , Poland
Wroclaw, , Poland
Kwei San Hsiang, , Taiwan
Tübingen, , Germany
Hopkinsville, Kentucky, United States
Buenos Aires, , Argentina
Debrecen, , Hungary
Kuei San Hsiang, , Taiwan
Praha 2, , Czechia
New York, New York, United States
Merida, , Mexico
Brandon, Florida, United States
Lake Charles, Louisiana, United States
Crete, , Greece
Guadalajara, , Mexico
Galati, , Romania
Málaga, , Spain
Charlotte, North Carolina, United States
Bogota, , Colombia
Canton, New York, United States
Bucaramanga, , Colombia
Monterrey, , Mexico
San Juan, , Argentina
Quilmes, , Argentina
Leon, , Mexico
Santiago, , Chile
Monteria, , Colombia
Szeged, , Hungary
Quilmes, , Argentina
Barranquilla, , Colombia
Colleyville, Texas, United States
Larisa, , Greece
Bogota, , Colombia
Chia, , Colombia
Cologne, , Germany
Taichung City, , Taiwan
Edmonton Ab, , Canada
Cuernavaca, , Mexico
Gainesville, Florida, United States
Chihuahua, , Mexico
Detroit, Michigan, United States
Milano, , Italy
Incheon, , Korea, Republic Of
Lima, , Peru
Taichung City, , Taiwan
Lima, , Peru
Barranquilla, , Colombia
Belgrade, , Serbia
Barcelona, , Spain
Plantation, Florida, United States
Atlanta, Georgia, United States
Mendoza, , Argentina
Makati, , Philippines
Taoyuan City, , Taiwan
Haidari Athens, , Greece
Seoul, , Korea, Republic Of
Hershey, Pennsylvania, United States
Calgary, , Canada
Toronto, , Canada
Herne, , Germany
Athens, , Greece
Catania, , Italy
Birmingham, Alabama, United States
Freiburg, , Germany
Davao, , Philippines
Hershey, Pennsylvania, United States
Taipei City, , Taiwan
Taiyuan City, , Taiwan
Patients applied
Trial Officials
UCB Cares
Study Director
001 844 599 2273 (UCB)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials